ELAN

Elanco Animal Health Incorporated

9.042
0.442 (5.14%)
Company Name Stock Ticker Symbol Market Type
Elanco Animal Health Incorporated ELAN NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
0.442 5.14% 9.042 20:00:00
Open Price Low Price High Price Close Price Prev Close
8.83 8.75 9.225 9.22 8.60
more quote information »

Recent News

Date Time Source Heading
5/25/202308:00BWElanco to Participate in Stifel 2023 Jaws and Paws..
5/19/202316:17EDGARSecurities Registration: Employee Benefit Plan (s-8)
5/09/202309:09EDGARQuarterly Report (10-q)
5/09/202306:35EDGARCurrent Report Filing (8-k)
5/09/202306:34BWElanco Animal Health Reports First Quarter 2023 Results
5/02/202309:21DJNElanco Receives USDA License for Canine Virus Treatment
5/02/202308:30BWElanco Announces Breakthrough Treatment for Deadly Canine..
5/01/202319:35PRNUSCalifornia Dairies, Inc. and DSM Venturing Complete..
5/01/202315:47DJNElanco Animal Health's Varenzin-CA1 Gets Conditional FDA..
4/18/202308:00BWElanco Confirms Date and Conference Call for First Quarter..
4/06/202308:32EDGARProxy Statement (definitive) (def 14a)
4/06/202308:32EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
4/05/202316:17EDGARStatement of Changes in Beneficial Ownership (4)
4/04/202319:15EDGARStatement of Changes in Beneficial Ownership (4)
3/24/202316:04EDGARInitial Statement of Beneficial Ownership (3)
3/15/202316:22EDGARStatement of Changes in Beneficial Ownership (4)
3/14/202308:00PRNUSTyson Ventures invests in Athian's cloud-based carbon credit..
3/09/202308:00BWElanco to Participate in the Barclays Global Healthcare..
3/06/202318:53EDGARStatement of Changes in Beneficial Ownership (4)
3/06/202318:52EDGARStatement of Changes in Beneficial Ownership (4)
3/06/202318:52EDGARStatement of Changes in Beneficial Ownership (4)
3/06/202318:50EDGARStatement of Changes in Beneficial Ownership (4)
3/06/202318:43EDGARStatement of Changes in Beneficial Ownership (4)
3/06/202318:42EDGARStatement of Changes in Beneficial Ownership (4)
3/06/202318:41EDGARStatement of Changes in Beneficial Ownership (4)
3/01/202312:40EDGARAmended Current Report Filing (8-k/a)
2/27/202308:00BWElanco to Participate in the Cowen 43rd Annual Health Care..
2/23/202316:45BWElanco to Participate in the Bank of America 2023 Animal..
2/21/202306:31EDGARCurrent Report Filing (8-k)
2/21/202306:30BWElanco Animal Health Reports Fourth Quarter and Full Year..
2/20/202316:30BWElanco Adds Animal Health Veteran to Executive Committee
2/14/202313:45EDGARAmended Statement of Ownership (sc 13g/a)
2/09/202316:03EDGARAmended Statement of Ownership (sc 13g/a)
2/09/202311:22EDGARAmended Statement of Ownership (sc 13g/a)
2/03/202316:08EDGARStatement of Changes in Beneficial Ownership (4)
2/03/202308:30BWElanco Confirms Date and Conference Call for Fourth Quarter..
1/09/202308:03EDGARCurrent Report Filing (8-k)
1/05/202318:33EDGARStatement of Changes in Beneficial Ownership (4)
1/03/202317:10EDGARStatement of Changes in Beneficial Ownership (4)
1/03/202308:00BWElanco to Participate in the 41st Annual J.P. Morgan..
12/22/202207:02EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
12/09/202216:03EDGARAmended Statement of Ownership (sc 13g/a)
12/09/202210:48BWElanco Announces FDA Approval of Bexacatâ„¢ (bexagliflozin..
12/02/202217:13EDGARStatement of Changes in Beneficial Ownership (4)
12/02/202217:11EDGARStatement of Changes in Beneficial Ownership (4)
12/02/202217:08EDGARStatement of Changes in Beneficial Ownership (4)
12/02/202217:08EDGARStatement of Changes in Beneficial Ownership (4)
12/02/202217:07EDGARStatement of Changes in Beneficial Ownership (4)
12/02/202217:06EDGARStatement of Changes in Beneficial Ownership (4)
12/02/202217:05EDGARStatement of Changes in Beneficial Ownership (4)